Synonyms: | |
Status: | Phase 2 |
Entry Type: | Small molecule |
Molecule Category: | UNKNOWN |
UNII: | 2B218X5QIY |
InChI Key | OCKIPDMKGPYYJS-ZDUSSCGKSA-N |
---|---|
Smile | |
InChI |
|
Property Name | Value |
---|---|
Molecular Formula | C13H16N2O |
Molecular Weight | 216.28 |
AlogP | 1.48 |
Hydrogen Bond Acceptor | 3.0 |
Hydrogen Bond Donor | 0.0 |
Number of Rotational Bond | 0.0 |
Polar Surface Area | 25.36 |
Molecular species | NEUTRAL |
Aromatic Rings | 1.0 |
Heavy Atoms | 16.0 |
Primary Target | |
---|---|
nicotinic acetylcholine receptor α7 subunit |
Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
---|---|---|---|---|---|---|
Ion channel
Ligand-gated ion channel
5HT3 receptor
|
- | - | - | 12 | - | |
Ion channel
Ligand-gated ion channel
Nicotinic acetylcholine receptor
Nicotinic acetylcholine receptor alpha subunit
|
340 | - | - | 3-3 | - | |
Ion channel
Ligand-gated ion channel
Nicotinic acetylcholine receptor
Nicotinic acetylcholine receptor beta subunit
|
- | - | - | 140 | - |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Schizophrenia | 2 | D012559 | ClinicalTrials |
Alzheimer Disease | 1 | D000544 | ClinicalTrials |
Resources | Reference |
---|---|
ChEMBL | CHEMBL2151437 |
DrugBank | DB12145 |
FDA SRS | 2B218X5QIY |
Guide to Pharmacology | 7697 |
SureChEMBL | SCHEMBL1459640 |
ZINC | ZINC000033961869 |